Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Nov. 30, 2015	Nov. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,573,050)	$ (6,943,697)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	72,422	40,258
Share based compensation	724,526	1,173,639
Loss on assets and securities held for sale	10,196	$ 33,707
Loss on settlement of capital lease	8,820
Accretion expense	$ 129,354	$ 539,319
Beneficial conversion feature		2,324,759
Amortization of deferred financing costs		$ 60,523
Change in fair value of warrant liability	$ (123,393)
Change in fair value of put embedded in note payable	$ 3,134
Net changes in assets and liabilities
Other receivable		$ 20,000
Prepaid expenses and other current assets	$ 24,844	46,226
Refundable deposits	(3,600)	(278,952)
Accounts payable	60,912	251,599
Accrued expenses	198,350	37,190
Interest payable	29,649	63,712
NET CASH USED IN OPERATING ACTIVITIES	(2,437,836)	$ (2,631,717)
Cash Flows from Investing Activities
Note receivable	(50,000)
Proceeds received from settlement of capital lease	$ 2,897
Proceeds from sale of investment		$ 1,142,926
Purchase of equipment	$ (151,830)	(65,645)
Net cash used in (provided by) investing activities	(198,933)	1,077,281
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of notes	1,200,000	$ 615,000
Payment of debt issuance costs	$ (88,592)
Proceeds from issuance of common stock and warrants, net		$ 750,000
Re-purchase of common stock and warrants	$ (111,563)
Proceeds from issuance of Series B preferred stock and warrant, net	$ 1,945,244
Payment of convertible notes		$ (100,000)
Payment of short-term debt	$ (107,250)	(30,955)
Payment of capital lease obligation	(42,407)	$ (93,840)
Deferred offering costs	(151,566)
NET CASH PROVIDED BY FINANCING ACTIVITIES	2,643,866	$ 1,140,205
Net increase in cash and cash equivalents	7,097	(414,231)
Cash and cash equivalents at the beginning of the period	257,820	483,408
Cash and cash equivalents at the end of the period	264,917	$ 69,177
Supplemental Disclosure of Non-Cash Financing Activities
Warrant liability associated with note payable	$ 150,544
Placement agent warrants issued with note payable	16,800
Beneficial conversion feature associated with the convertible notes		$ 45,746
Warrants issued with convertible notes		127,289
Issuance on lease financing for fixed assets		318,603
Securities held for sale exchanged for common stock and preferred shares		1,000,000
Common stock and warrants issued for conversion of debt		3,558,413
Accrued offering costs		38,950
Securities exchanged for preferred shares		256,633
Financing of insurance premium through short-term debt	$ 107,250	$ 93,840
Note receivable received for sale of assets	75,000
Warrants issued to placement agents	175,241
Series B Preferred PIK dividend	164,454
Series B Preferred Stock accrued dividends	195,057
Capital lease settled against deposit	$ 227,235